rs11719981

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_153460.4(IL17RC):​c.977C>T​(p.Ala326Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00214 in 1,604,918 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A326T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 8 hom. )

Consequence

IL17RC
NM_153460.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, single submitter B:4

Conservation

PhyloP100: 0.833

Publications

5 publications found
Variant links:
Genes affected
IL17RC (HGNC:18358): (interleukin 17 receptor C) This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
IL17RC Gene-Disease associations (from GenCC):
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • candidiasis, familial, 9
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043530464).
BP6
Variant 3-9928404-C-T is Benign according to our data. Variant chr3-9928404-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 542545.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 193 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RCNM_153460.4 linkc.977C>T p.Ala326Val missense_variant Exon 11 of 19 ENST00000403601.8 NP_703190.2 Q8NAC3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RCENST00000403601.8 linkc.977C>T p.Ala326Val missense_variant Exon 11 of 19 1 NM_153460.4 ENSP00000384969.3 Q8NAC3-2
ENSG00000288550ENST00000683484.1 linkn.893C>T non_coding_transcript_exon_variant Exon 10 of 24 ENSP00000507040.1 A0A804HIF2

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
194
AN:
152242
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00166
AC:
401
AN:
241914
AF XY:
0.00159
show subpopulations
Gnomad AFR exome
AF:
0.000922
Gnomad AMR exome
AF:
0.00198
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000555
Gnomad FIN exome
AF:
0.000478
Gnomad NFE exome
AF:
0.00197
Gnomad OTH exome
AF:
0.00119
GnomAD4 exome
AF:
0.00223
AC:
3242
AN:
1452560
Hom.:
8
Cov.:
40
AF XY:
0.00219
AC XY:
1579
AN XY:
722320
show subpopulations
African (AFR)
AF:
0.000542
AC:
18
AN:
33200
American (AMR)
AF:
0.00174
AC:
76
AN:
43580
Ashkenazi Jewish (ASJ)
AF:
0.0000772
AC:
2
AN:
25902
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39588
South Asian (SAS)
AF:
0.00152
AC:
131
AN:
85914
European-Finnish (FIN)
AF:
0.000624
AC:
31
AN:
49656
Middle Eastern (MID)
AF:
0.000350
AC:
2
AN:
5722
European-Non Finnish (NFE)
AF:
0.00256
AC:
2841
AN:
1108960
Other (OTH)
AF:
0.00228
AC:
137
AN:
60038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
172
345
517
690
862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00127
AC:
193
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.00129
AC XY:
96
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41594
American (AMR)
AF:
0.00118
AC:
18
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00190
AC:
129
AN:
68022
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00152
Hom.:
6
Bravo
AF:
0.00132
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.00175
AC:
15
ExAC
AF:
0.00168
AC:
204
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00249

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

IL17RC-related disorder Benign:1
Jan 16, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Candidiasis, familial, 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.0
DANN
Benign
0.75
DEOGEN2
Benign
0.023
.;.;.;T;.;.;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.82
T;.;T;T;T;T;T;T;T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.0044
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.46
.;.;.;N;.;.;.;.;.
PhyloP100
0.83
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.33
.;N;N;N;.;N;N;N;N
REVEL
Benign
0.014
Sift
Benign
0.66
.;T;T;T;.;T;T;T;T
Sift4G
Benign
0.87
T;T;T;T;.;T;T;T;T
Polyphen
0.0090, 0.46, 0.020
.;B;.;P;B;.;B;.;.
Vest4
0.16
MVP
0.030
MPC
0.24
ClinPred
0.0030
T
GERP RS
-0.082
Varity_R
0.060
gMVP
0.37
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11719981; hg19: chr3-9970088; API